Terms: = Brain cancer AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2 AND Treatment
4 results:
1. A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Wen PY; Reardon DA; Armstrong TS; Phuphanich S; Aiken RD; Landolfi JC; Curry WT; Zhu JJ; Glantz M; Peereboom DM; Markert JM; LaRocca R; O'Rourke DM; Fink K; Kim L; Gruber M; Lesser GJ; Pan E; Kesari S; Muzikansky A; Pinilla C; Santos RG; Yu JS
Clin Cancer Res; 2019 Oct; 25(19):5799-5807. PubMed ID: 31320597
[TBL] [Abstract] [Full Text] [Related]
2. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based cancer Vaccine.
Guo J; Muse E; Christians AJ; Swanson SJ; Davila E
Cancer Immunol Res; 2019 Sep; 7(9):1523-1534. PubMed ID: 31266784
[TBL] [Abstract] [Full Text] [Related]
3. Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy.
Liu G; Akasaki Y; Khong HT; Wheeler CJ; Das A; Black KL; Yu JS
Oncogene; 2005 Aug; 24(33):5226-34. PubMed ID: 15897911
[TBL] [Abstract] [Full Text] [Related]
4. Specific detection of the endogenous transient receptor potential (TRP)-1 protein in liver and airway smooth muscle cells using immunoprecipitation and Western-blot analysis.
Ong HL; Chen J; Chataway T; Brereton H; Zhang L; Downs T; Tsiokas L; Barritt G
Biochem J; 2002 Jun; 364(Pt 3):641-8. PubMed ID: 12049627
[TBL] [Abstract] [Full Text] [Related]
